Beyond Basic Beta Content Hub Bull vs. Bear: How Healthy Are Biotech ETFs? By The VettaFi WritersMay 10, 2023
ETF Building Blocks Content Hub Biotech ETFs’ Performance Deserves A Look By Nick Peters-GoldenApril 19, 2023
ETF Building Blocks Content Hub Look to SBIO for Biotech Exposure By Elle Caruso FitzgeraldDecember 12, 2022
Expert Insights Chart of the Week: What Sector Looks Healthiest to Advisors By Todd RosenbluthNovember 10, 2022
ETF Building Blocks Content Hub SBIO Rallied While Major Indexes Declined Last Week By Elle Caruso FitzgeraldOctober 4, 2022
ETF Building Blocks Content Hub SBIO Outpaced XBI, IBB in Volatile Last Week By Elle Caruso FitzgeraldSeptember 21, 2022
ETF Building Blocks Content Hub SBIO Was ALPS’ Top Performing ETF in August By Elle Caruso FitzgeraldSeptember 1, 2022
ETF Building Blocks Content Hub SBIO Rallies on M&A Announcements By Elle Caruso FitzgeraldAugust 10, 2022
Featured Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal By Max ChenAugust 5, 2022
Featured Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics By Max ChenAugust 4, 2022
ETF Building Blocks Content Hub SBIO Increases on Biotech’s Sustained Rebound By Elle Caruso FitzgeraldJuly 20, 2022
